Evidence map›Paper›PMID 15781478›Full record

ReviewThe Journal of cell biology2005

Golgi positioning: are we looking at the right MAP?

Francis A Barr, Johannes Egerer

Abstract readReview
In one paragraph

Review in The Journal of cell biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cell polarity as a regulator of cancer cell behavior plasticity.Annual review of cell and developmental biology · 2012
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Dyggve-Melchior-Clausen syndrome: chondrodysplasia resulting from defects in intracellular vesicle traffic.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Francis A BarrMax-Planck-Institute of Biochemistry, Martinsried, 82152 Germany. barr@biochem.mpg.de
Johannes Egerer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the characteristics of the mammalian Golgi is its position adjacent to the nucleus. This characteristic is maintained through the action of the microtubule (MT) minus end-directed motor dynein and MT-associated proteins (MAPs). Recent findings suggest that GMAP-210, a member of the golgin family of proteins, may help to link Golgi membranes and vesicles with the MT cytoskeleton. However, there are good grounds to doubt that either GMAP-210 or its yeast homologue Rud3p is a MAP. Instead, they appear to function in vesicle trafficking events at the Golgi together with the GTPase ARF1 and a small membrane protein, Erv14. As such, the interesting question of how the Golgi interacts with MTs may well remain open to further investigation.

Indexed as

ADP-Ribosylation Factor 1AnimalsCytoskeletal ProteinsGolgi ApparatusHumansIntracellular MembranesMembrane ProteinsMicrotubule-Associated ProteinsMicrotubulesNuclear ProteinsProtein TransportSaccharomyces cerevisiae ProteinsTransport VesiclesADP-Ribosylation Factor 1Cytoskeletal ProteinsErv14 protein, S cerevisiaeMembrane ProteinsMicrotubule-Associated ProteinsNuclear ProteinsSaccharomyces cerevisiae ProteinsTRIP11 protein, human

Identifiers

PMID15781478
PMCPMC2171853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.